Sarcura is developing an instrument platform for the GMP manufacturing of autologous cell therapies. Its platform combines microfluidic processing with silicon chip technology to enable real-time process control and manipulation on a cellular level supporting a fully automated manufacturing system. The company’s target is to scale global manufacturing capacity for patient-specific cell therapy cancer treatments …